INFI 7.42 Infinity Pharmaceuticals $INFI added to my watch

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Quaker Houghton Completes Acquisition of Dipsol Chemicals Quaker Houghton, a prominent leader in the industrial process fluids sector, has announced the successful completion of its acquisition of Dipsol Chemicals Co., Ltd. Dipsol is renowned for providing advanced surface treatment and plating solutions primarily tailored for the automotive sector and other industrial...

EnsembleIQ Unveils 2025 GenNext Honorees In an exciting announcement from EnsembleIQ, the list of 2025 GenNext honorees has been revealed, showcasing the young talents leading change in grocery retail. These individuals are not just making a mark in their respective organizations; they are also influencing the broader industry landscape with their innovative ideas and...

Investors Encouraged to Act on Metagenomi Losses Faruqi & Faruqi, LLP, a prominent law firm specializing in securities litigation, urges shareholders of Metagenomi, Inc. to assess their financial setbacks following alarming developments in the company's recent activities. Those who have experienced losses exceeding $50,000 are particularly encouraged to reach out to the...

Understanding Recent Trends in QuantumScape Corp's Short Interest QuantumScape Corp (NYSE: QS) has experienced a shift in short interest, with a notable decline of 5.31% since its previous report. Recent data reveals that 49.69 million shares have been sold short, representing 11.05% of the total shares available for trading. This trend indicates that, based on current...

Understanding the Data Breach Involving Via Credit Union The team at Murphy Law Firm is currently looking into legal claims for individuals affected by a recent data breach at Via Credit Union (ViaCU). This incident has raised significant concerns over the handling of sensitive information and the responsibility of financial institutions to maintain appropriate security...